Shahram Habibzadeh

Dr. Shahram Habibzadeh


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2018 in Virus Research
Verified
Journal Article
Closed access
HPHadi Peeridogaheh
Hadi Peeridogaheh
ZMZahra Meshkat
Zahra Meshkat
SHShahram Habibzadeh
Shahram Habibzadeh
MAMohsen Arzanlou
Mohsen Arzanlou
JSJafar Mohammad Shahi
Jafar Mohammad Shahi
RTRoghayeh Teimourpour
Roghayeh Teimourpour

7 March 2012 in BMC Public Health
Verified
Journal Article
Open access
PDF file
SASaeid Sadeghieh Ahari
Saeid Sadeghieh Ahari
SHShahram Habibzadeh
Shahram Habibzadeh
MYMoharram Yousefi
Moharram Yousefi
FAFirouz Amani
Firouz Amani
RAReza Abdi
Reza Abdi
Background: Community assessment is a core function of public health. In such assessments, a commitment to community participation and empowerment is at the heart of the WHO European Healthy Cities Network, reflecting its origins in health for all and the Ottawa Charter for Health Promotion. This study employs a participation and empowerment plan in order to conduct community assessment. Methods: The method of participatory action research (PAR) was used. The study was carried out in an area of high socio-economic deprivation in Ardabil, a city in the northwest of Iran, which is currently served by a branch of the Social Development Center (SDC). The steering committee of the project was formed by some university faculty members, health officials and delegates form Farhikhteh non-governmental organization and representatives from twelve blocks or districts of the community. Then, the representatives were trained and then conducted focus groups in their block. The focus group findings informed the development of the questionnaire. About six hundred households were surveyed and study questionnaires were completed either during face-to-face interviews by the research team (in case of illiteracy) or via self-completion. The primary question for the residents was: 'what is the most important health problem in your community? Each health problem identified by the community was weighted based on the frequency it was selected on the survey, and steering committee perception of the problem's seriousness, urgency, solvability, and financial load. Results: The main problems of the area appeared to be the asphalt problem, lack of easy access to medical centers, addiction among relatives and unemployment of youth. High participation rates of community members in the steering committee and survey suggest that the PAR approach was greatly appreciated by the community and that problems identified through this research truly reflect community opinion. Conclusions: Participatory action research is an effective method for community assessments. However, researchers must rigorously embrace principles of mutual cooperation, respect for public ideas, and a robust belief in community empowerment in order to pave the way for responsible and active citizen participation in the various stages of research.

1 November 2013 in American Journal of Infection Control
Verified
Journal Article
Closed access
EJElham Jannati
Elham Jannati
MAMohsen Arzanlou
Mohsen Arzanlou
SHShahram Habibzadeh
Shahram Habibzadeh
SMSaeed Mohammadi
Saeed Mohammadi
PAParisa Ahadi
Parisa Ahadi
EKEbrahim Kazemi
Ebrahim Kazemi

1 September 2012
Verified
Journal Article
Open access
EJE. Jannati
E. Jannati
MRM. Roshani
M. Roshani
MAM. Arzanlou
M. Arzanlou
SHShahram Habibzadeh
Shahram Habibzadeh
GRG. Rahimi
G. Rahimi
RSR. Shapuri
R. Shapuri
Background and Objectives: Group B Streptococci (GBS) is a major cause of neonatal and maternal infections. The aim of this study was to determine the serotype distribution and antibiotic resistance profile of GBS strains isolated from pregnant women in Ardabil. Materials and Methods: Antibiotic resistance of 56 GBS isolates was investigated using E-test strips and disk-diffusion method. Serotyping was performed using capsular antiserum. Results: The results of MIC tests showed all isolates were susceptible to ampicillin, vancomycin and penicillin. One isolate (1.7%) showed reduced susceptibility pattern to penicillin (MIC; 0.25 mu g/ml). There were 3 (5.3%) isolates semi-sensitive (0.25-1 mu g/ml) to erythromycin (2; 0.5 mu g/ml and 1; 0.38 mu g/ml) and 2 (3.5%) isolates to clindamycin (1; 0.5 mu g/ml, 1; 0.38 mu g/ml). Additionally, 2 (3.5%) isolates were resistant to clindamycin (1; 16 mu g/ml, 1; 2 mu g/ml). According to the disk diffusion test, 47 (83.9%), 8 (14.2%) and 7 (12.5%) isolates were resistant to Co-trimoxazole, ciprofloxacin and ceftriaxone respectively. Serotypes V (19.6%), II (12.5%) and IV (12.5%) were the most frequent followed by serotypes III (10.7%) and VI (10.7%), Ib (8.9%), Ia (7/1%), VII (5/3%) and VIII (5/3%); 7.1% of strains were nontypeable. Conclusions: In this study, most isolates were sensitive to common antibiotics, but increased resistance to other antibiotics indicates the importance of monitoring of antibiotic resistance in group B streptococci over time.

1 December 2017
Verified
Journal Article
Open access
EMEslam Moradi-Asl
Eslam Moradi-Asl
AHAhmad Ali Hanafi-Bojd
Ahmad Ali Hanafi-Bojd
YRYavar Rassi
Yavar Rassi
HVHassan Vatandoost
Hassan Vatandoost
MMMehdi Mohebali
Mehdi Mohebali
SRSayena Rafizadeh
Sayena Rafizadeh
Background: Visceral leishmaniasis is one of the most important vector borne diseases in the world, transmitted by sand flies. Despite efforts to prevent the spread of the disease, cases continue worldwide. In Iran, the disease usually occurs in children under 10 years. In the absence of timely diagnosis and treatment, the mortality rate is 95-100%. The main objective of this study was to determine the spatial and temporal distribution of visceral leishmaniasis as well as its correlation with climatic factors for determining high-risk areas in an endemic focus in northwestern Iran. Methods: In this cross-sectional study, data on VL cases were collected from local health centers in Ardabil Province, Iran during 2001-2015 to establish a geodatabase using ArcGIS10.3. Data analysis was conducted using SPSS23 and ArcMap Spatial Analyst. MaxEnt model was used to determine ecologically suitable nichesfor the disease. Results: Two hotspots were found in Meshkinshahr and Germi counties with 59% and 23% of total cases, respectively. There was an increase in the incidence rate of VL in Ardabil County from 2.9 in 2009 to 9.2/ 100,000 population in 2015. There was no spatial autocorrelation between county and total number of cases (P> 0.05). Higher NDVI, lower altitude and southern aspects had positive effects on the presence probability of VL. Conclusion: The number of cases of this disease have been rising since 2013 and doubled in 2015. According to the derived distribution maps, the disease is spreading to new locations such as Ardabil and Namin counties.

12 October 2015 in Archives of Medical Science
Verified
Journal Article
Open access
AYAbbas Yazdanbod
Abbas Yazdanbod
SSSina Salimian
Sina Salimian
SHShahram Habibzadeh
Shahram Habibzadeh
AHAfshin Hooshyar
Afshin Hooshyar
NMNasrollah Maleki
Nasrollah Maleki
MNMaryam Norouzvand
Maryam Norouzvand
Whether patients with functional dyspepsia (FD) should receive Helicobacter pylori (H. pylori) eradication therapy remains controversial. The objective of this trial was to evaluate the effect of H. pylori eradication therapy on dyspeptic symptoms of patients with FD. A prospective, randomized, placebo-controlled trial of H. pylori eradication for FD was conducted. A total of 720 FD patients diagnosed by Rome III criteria were consecutively enrolled. We randomly assigned 186 H. pylori infected patients with FD to receive quadruple therapy for 14 days and 173 such patients to receive identical-appearing placebos. Severity of abdominal symptoms was assessed with the Glasgow Dyspepsia Severity Score (GDSS), and eradication of H. pylori by 13C-urea breath test was evaluated during one year. The rate of eradication of H. pylori infection was 87.1% in the treatment group and 2.9% in the placebo group at 6 weeks (p = 0.001). The mean GDSS at 12 months was 4.9 ±2.8 in the treatment group, as compared to 5.2 ±3.4 in the placebo group (p = 0.064). The scores in both groups were lower than those at baseline. According to the intention-to-treat analysis, at 12 months, there was no significant difference between groups in the rate of successful treatment (48.6% in the treatment group and 51.2% in the placebo group; p = 0.84). There was no significant difference in mean symptom scores between the two treatment groups at any point during follow-up. The results of our study provide no evidence that H. pylori eradication leads to relief of symptoms 12 months after treatment, and there is a need for further studies.